However, he said in the letter, even after several months of the announcement, not a single patient has been able to reap the benefits of this scheme, "threatening the survival of 432 patients, mainly children below six years of age". Most of these children suffer from Lysosomal Storage Disorders (LSD) such as gaucher, pompe, MPS I, MPS II and fabry disease, he said. According to the Ministry of Health and Family Welfare crowdfunding platform, around 208 Lysosomal Storage Disorder patients can immediately be put on therapy since the Drugs Controller General of India-approved treatments for most of these diseases have been available in India for many yeas, Gandhi said.